McCormick, David
- University of Oregon · Neurosciences (NIH department code)
- Iit Research Institute (no department on record)
- University of Oregon (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #813
- Rising Star
- Top 5% Funded
- R01 Holder
- Long-Funded
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Neurosciences
NIH Funding · FY2023
Linked Award Amount
$4.7M
Full award amounts, FY2023
Award Records
6
Records listing this PI
Award-Linked Rank
#813
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing McCormick, David as a PI. Multi-PI records show the full award amount for context.
- 75N91022C00010-P00002-9999-1N01Contact PIPRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS$1.5Maward amount
- $811.3Kaward amount
- 4R01NS118461-02R01Contact PIBrain States and Flexible BehaviorUniversity of Oregon · Neurosciences (NIH department code)$748.7Kaward amount
- 75N91019D00013-0-759102300001-1N01Contact PIBase Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013$659.5Kaward amount
- 75N91019D00013-P00004-759102000001-1N01Contact PITASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTIONPERIOD OF PERFORMANCE: 09/21/2020 - 03/31/2023$644.6Kaward amount
- 261201500024I-P00007-26100005-1N01Contact PILFA-9 (mPGES-1/5-LOX Inhibitor): Preclinical Studies to Support a Clinical Trial,$418.7Kaward amount
Award organizations
Organizations that administered FY2023 awards listing McCormick, David as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardIit Research Institute
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007$2M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #2313
- 2007Entered Top 25% NationallyRanked #2313
- 2008Entered Top 10% NationallyRanked #1806
- 2008Multi-Institutional ResearchAwards at 2 institutions
- 2009$5M Cumulative Funding
- 2010$10M Cumulative Funding
- 2010Entered Top 5% NationallyRanked #311
- 2012R01 Grant Holder
- 2018$25M Cumulative Funding